Cargando…
High‐resolution HLA class II sequencing of Swedish multiple sclerosis patients
Multiple sclerosis (MS) is a chronic neurological disease believed to be caused by autoimmune pathogenesis. The aetiology is likely explained by a complex interplay between inherited and environmental factors. Genetic investigations into MS have been conducted for over 50 years, yielding >100 ass...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545082/ https://www.ncbi.nlm.nih.gov/pubmed/35959717 http://dx.doi.org/10.1111/iji.12594 |
_version_ | 1784804741257101312 |
---|---|
author | Akel, Omar Zhao, Lue Ping Geraghty, Daniel E Lind, Alexander |
author_facet | Akel, Omar Zhao, Lue Ping Geraghty, Daniel E Lind, Alexander |
author_sort | Akel, Omar |
collection | PubMed |
description | Multiple sclerosis (MS) is a chronic neurological disease believed to be caused by autoimmune pathogenesis. The aetiology is likely explained by a complex interplay between inherited and environmental factors. Genetic investigations into MS have been conducted for over 50 years, yielding >100 associations to date. Globally, the strongest linkage is with the human leukocyte antigen (HLA) HLA‐DRB5*01:01:01‐DRB1*15:01:01‐DQA1*01:02:01‐DQB1*06:02:01 haplotype. Here, high‐resolution sequencing of HLA was used to determine the alleles of DRB3, DRB4, DRB5, DRB1, DQA1, DQB1, DPA1 and DPB1 as well as their extended haplotypes and genotypes in 100 Swedish MS patients. Results were compared to 636 population controls. The heterogeneity in HLA associations with MS was demonstrated; among 100 patients, 69 extended HLA‐DR‐DQ genotypes were found. Three extended HLA‐DR‐DQ genotypes were found to be correlated to MS; HLA‐DRB5*01:01:01‐DRB1*15:01:01‐DQA1*01:02:01‐DQB1*06:02:01 haplotype together with (A) HLA‐DRB4*01:01:01//DRB4*01:01:01:01‐DRB1*07:01:01‐DQA1*02:01//02:01:01‐DQB1*02:02:01, (B) HLA‐DRBX*null‐DRB1*08:01:01‐DQA1*04:01:01‐DQB1*04:02:01, and (C) HLA‐DRB3*01:01:02‐DRB1*03:01:01‐DQA1*05:01:01‐DQB1*02:01:01. At the allelic level, HLA‐DRB3*01:01:02 was considered protective against MS. However, when combined with HLA‐DRB3*01:01:02‐DRB1*03:01:01‐DQA1*05:01:01‐DQB1*02:01:01, this extended haplotype was considered a predisposing risk factor. This highlights the limitations as included with investigations of single alleles relative to those of extended haplotypes/genotypes. In conclusion, with 69 genotypes presented among 100 patients, high‐resolution sequencing was conducted to underscore the wide polymorphisms present among MS patients. Additional studies in larger cohorts will be of importance to define MS among the patient group not associated with HLA‐DRB5*01:01:01‐DRB1*15:01:01‐DQA1*01:02:01‐DQB1*06:02:01. |
format | Online Article Text |
id | pubmed-9545082 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95450822022-10-14 High‐resolution HLA class II sequencing of Swedish multiple sclerosis patients Akel, Omar Zhao, Lue Ping Geraghty, Daniel E Lind, Alexander Int J Immunogenet Hla and Disease Multiple sclerosis (MS) is a chronic neurological disease believed to be caused by autoimmune pathogenesis. The aetiology is likely explained by a complex interplay between inherited and environmental factors. Genetic investigations into MS have been conducted for over 50 years, yielding >100 associations to date. Globally, the strongest linkage is with the human leukocyte antigen (HLA) HLA‐DRB5*01:01:01‐DRB1*15:01:01‐DQA1*01:02:01‐DQB1*06:02:01 haplotype. Here, high‐resolution sequencing of HLA was used to determine the alleles of DRB3, DRB4, DRB5, DRB1, DQA1, DQB1, DPA1 and DPB1 as well as their extended haplotypes and genotypes in 100 Swedish MS patients. Results were compared to 636 population controls. The heterogeneity in HLA associations with MS was demonstrated; among 100 patients, 69 extended HLA‐DR‐DQ genotypes were found. Three extended HLA‐DR‐DQ genotypes were found to be correlated to MS; HLA‐DRB5*01:01:01‐DRB1*15:01:01‐DQA1*01:02:01‐DQB1*06:02:01 haplotype together with (A) HLA‐DRB4*01:01:01//DRB4*01:01:01:01‐DRB1*07:01:01‐DQA1*02:01//02:01:01‐DQB1*02:02:01, (B) HLA‐DRBX*null‐DRB1*08:01:01‐DQA1*04:01:01‐DQB1*04:02:01, and (C) HLA‐DRB3*01:01:02‐DRB1*03:01:01‐DQA1*05:01:01‐DQB1*02:01:01. At the allelic level, HLA‐DRB3*01:01:02 was considered protective against MS. However, when combined with HLA‐DRB3*01:01:02‐DRB1*03:01:01‐DQA1*05:01:01‐DQB1*02:01:01, this extended haplotype was considered a predisposing risk factor. This highlights the limitations as included with investigations of single alleles relative to those of extended haplotypes/genotypes. In conclusion, with 69 genotypes presented among 100 patients, high‐resolution sequencing was conducted to underscore the wide polymorphisms present among MS patients. Additional studies in larger cohorts will be of importance to define MS among the patient group not associated with HLA‐DRB5*01:01:01‐DRB1*15:01:01‐DQA1*01:02:01‐DQB1*06:02:01. John Wiley and Sons Inc. 2022-08-12 2022-10 /pmc/articles/PMC9545082/ /pubmed/35959717 http://dx.doi.org/10.1111/iji.12594 Text en © 2022 The Authors. International Journal of Immunogenetics published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Hla and Disease Akel, Omar Zhao, Lue Ping Geraghty, Daniel E Lind, Alexander High‐resolution HLA class II sequencing of Swedish multiple sclerosis patients |
title | High‐resolution HLA class II sequencing of Swedish multiple sclerosis patients |
title_full | High‐resolution HLA class II sequencing of Swedish multiple sclerosis patients |
title_fullStr | High‐resolution HLA class II sequencing of Swedish multiple sclerosis patients |
title_full_unstemmed | High‐resolution HLA class II sequencing of Swedish multiple sclerosis patients |
title_short | High‐resolution HLA class II sequencing of Swedish multiple sclerosis patients |
title_sort | high‐resolution hla class ii sequencing of swedish multiple sclerosis patients |
topic | Hla and Disease |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545082/ https://www.ncbi.nlm.nih.gov/pubmed/35959717 http://dx.doi.org/10.1111/iji.12594 |
work_keys_str_mv | AT akelomar highresolutionhlaclassiisequencingofswedishmultiplesclerosispatients AT zhaolueping highresolutionhlaclassiisequencingofswedishmultiplesclerosispatients AT geraghtydaniele highresolutionhlaclassiisequencingofswedishmultiplesclerosispatients AT lindalexander highresolutionhlaclassiisequencingofswedishmultiplesclerosispatients |